Biofrontera (BFRI) Interest & Investment Income (2023 - 2025)
Biofrontera's (BFRI) quarterly Interest & Investment Income came in at $14000.0 in Q1 2025, little changed year-on-year from $14000.0 in Q1 2024, and down 6.67% quarter-over-quarter from $15000.0 in Q4 2024.
Biofrontera (BFRI) Interest & Investment Income (2023 - 2025) Analysis & Trends
Biofrontera's Interest & Investment Income history runs 3 years deep, the most recent figure standing at $14000.0 for Q1 2025.
- On a quarterly basis, Interest & Investment Income changed 0.0% year-over-year to $14000.0 in Q1 2025; TTM through Mar 2025 was $70000.0, a 22.22% decrease from a year earlier, with the FY2024 full-year figure at $71000.0, down 46.21% from the prior year.
- Interest & Investment Income retreated to $14000.0 in Q1 2025 per BFRI's latest filing, from $15000.0 in the prior quarter.
- Across five years, Interest & Investment Income topped out at $56000.0 in Q1 2023 and bottomed at $13000.0 in Q3 2023.
- The 3-year median for Interest & Investment Income is $17000.0 (2024), against an average of $24000.0.
- Biggest YoY gain for Interest & Investment Income was 30.77% in 2024; the steepest drop was 75.0% in 2024.
- Year by year, Interest & Investment Income stood at $21000.0 in 2023, then decreased by 28.57% to $15000.0 in 2024, then dropped by 6.67% to $14000.0 in 2025.
- Per Business Quant, the three latest BFRI Interest & Investment Income figures stand at $14000.0 (Q1 2025), $15000.0 (Q4 2024), and $17000.0 (Q3 2024).
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int & Inv Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 89.28 Bn | 87.42 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 35.97 Bn | 32.23 Bn | 1.97 Bn | - |
| 3 | Zoetis | 32.42 Bn | 30.48 Bn | 1.62 Bn | - |
| 4 | Takeda Pharmaceutical | 27.48 Bn | 23.42 Bn | 4.39 Bn | 32.85 Mn |
| 5 | United Therapeutics | 22.89 Bn | 20.73 Bn | 648.10 Mn | 41.80 Mn |
| 6 | RedHill Biopharma | 22.11 Bn | 22.11 Bn | - | - |
| 7 | Viatris | 20.44 Bn | 18.64 Bn | 1.16 Bn | - |
| 8 | Neurocrine Biosciences | 17.76 Bn | 16.44 Bn | 800.70 Mn | 28.10 Mn |
| 9 | Elanco Animal Health | 12.62 Bn | 12.19 Bn | 785.00 Mn | - |
| 10 | Biofrontera | 10.73 Mn | 4.32 Mn | 14.09 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2025 | 14,000.00 |
| Dec 31, 2024 | 15,000.00 |
| Sep 30, 2024 | 17,000.00 |
| Jun 30, 2024 | 24,000.00 |
| Mar 31, 2024 | 14,000.00 |
| Dec 31, 2023 | 21,000.00 |
| Sep 30, 2023 | 13,000.00 |
| Jun 30, 2023 | 42,000.00 |
| Mar 31, 2023 | 56,000.00 |